BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Pfizer Inc. (PFE)'s Zoetis (ZTS) Hauls in $2.24 Billion in IPO


2/1/2013 7:05:35 AM

Zoetis Inc., the animal-health company owned by Pfizer (PFE) Inc., raised $2.24 billion in its initial public offering, pricing the shares above the marketed price range. Zoetis sold 86.1 million shares at $26 each, according to a statement yesterday, after offering them for $22 to $25. Pfizer offered about 17 percent of Zoetis in the IPO, the biggest in the U.S. since Facebook Inc.’s last year. The price values Zoetis at $13 billion, making it the largest public company of its kind and one of the few focused solely on medicines for animals. Zoetis is benefiting as people consume more protein, a trend likely to increase as wealth grows in emerging countries such as Brazil, China and India, said Marshall Gordon, of New York-based money manager ClearBridge Investments LLC. As meat consumption grows, so will spending on animal medicine for cows, pigs and poultry, he said. “This is a play on global income growth -- as people rise in income, they eat more protein, and they have more companion animals,” Gordon said. The shares will start trading today, listed on the New York Stock Exchange under the symbol ZTS. The IPO was led by JPMorgan Chase & Co., Bank of America Corp. and Morgan Stanley. Zoetis, based in Madison, New Jersey, traces its roots back to 1952 as a Pfizer unit and has made at least 10 acquisitions to become the largest animal-health business, with $4.3 billion sales in 2012 -- about 20 percent of the $22 billion market.


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->